Abstract Joubert syndrome (JBTS) is an autosomal recessive multisystem disease characterized by cerebellar vermis aplasia, mental retardation, muscular hypotonia, an irregular breathing pattern in the neonatal period and abnormal eye movements. Some individuals have progressive renal failure characterized by nephronophthisis (NPHP) and/or retinal dystrophy. Homozygous deletions of NPHP1 on chromosome 2q13 have been identified in individuals with NPHP-associated JBTS. Recently, mutations in AHI1 on chromosome 6q23.3 were found in JBTS patients without NPHP. Here, by direct sequencing, we identify novel truncating mutations within AHI1 in affected patients from two families. One patient had the association of JBTS and NPHP with chronic renal failure. This is the first report of AHI1 mutations causing JBTS associated with NPHP, confirming the clinical and genetic heterogeneity of NPHP.
Introduction
Joubert syndrome (JBTS) is a rare autosomal recessive multisystem disorder characterized by aplasia of the cerebellar vermis, ataxia, abnormal eye movements, an abnormal breathing pattern in the neonatal period and psychomotor mental retardation [1, 2, 3] . On MRI brain imaging JBTS is characterized by a typical radiological finding, termed as "molar tooth sign" (MTS). This reflects a complex midbrain and hindbrain malformation consisting of an increased interpeduncular distance of the pontomesencephalic junction, cerebellar vermis aplasia and thickened, straight and elongated superior cerebellar peduncles [4, 5, 6] . The abnormal eye movements may comprise oculomotor apraxia (OMA) type Cogan, or difficulty with smooth eye pursuits and horizontal saccades with jerking head thrusting and nystagmus [7] . A related disorder has also been termed cerebello-oculorenal syndrome (CORS) [4, 8] . Some cases of JBTS may be associated with nephronophthisis and retinal dystrophy or retinal coloboma [3] . To date, two underlying gene defects in patients with JBTS have been described. Homozygous NPHP1 deletions on chromosome 2q13 have been reported in two cases of JBTS associated with nephronophthisis [9] . However, it has been noted that NPHP1 deletions are not a common cause of JBTS [10] . More recently, mutations in AHI1 on chromosome 6q23.3 were described in patients with JBTS, but without any evidence of renal involvement [11, 12] . In addition to these known gene defects, two loci have been mapped to 9q34.3 [13] and 11p12-q13.3 [14, 15] . Another putative locus was suggested by the detection of a chromosome 17p11 deletion in a patient with Smith-Magenis syndrome and a JBTS phenotype [16] . Here we report three novel mutations in AHI1 including, for the first time, the association of JBTS with NPHP.
Patients and methods
Criteria for Joubert syndrome were based on the following clinical hallmarks: presence of cerebellar vermis aplasia, cerebellar ataxia, psychomotor developmental delay, nystagmus and oculomotor apraxia. The patients also had NPHP by clinical history and by renal biopsy in patient II-4 from family F799. Venous blood samples from family members were obtained after informed consent. Genomic DNA was prepared according to standard methods. NPHP1 deletions were excluded by Southern-blot analysis and haplotype analysis (data not shown). In four JBTS individuals from consanguineous families known to be homozygous for microsatellite markers across the AHI1 gene region [17] , PCR of all coding sequences and the corresponding exon-intron boundaries of AHI1 where performed for mutational analysis. Primer sequences were determined using the UCSC sequence (http://genome.ucsc.edu/cgi-bin/hgGateway) and Primer3 software (http:// frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). PCR products were purified (Marligen Biosciences) prior to direct sequencing (Genetic Analyzer 3700, Applied Biosystems). An additional 20 JBTS individuals from non-consanguineous families were also screened. Ninety-six healthy individuals were screened as negative controls for each novel AHI1 mutation.
Results

Homozygosity mapping in F799
Previous haplotyping data from a total genome search revealed four consanguineous families (F799, F700, F427 and F216) with JBTS that were homozygous at the AHI1 gene locus on chromosome 6q23.3 [17] . High-resolution haplotyping using 15 microsatellite markers was performed in these families. A region of homozygosity of more than 27 Mb was confirmed in family F799, delimited by flanking markers D6S303 and D6S1704 (Fig. 1) . However, regions of homozygosity were found to be interrupted by heterozygous markers in consanguineous families F700, F427 and F216, excluding them from this locus.
Mutational analysis of the AHI1 gene Mutational analysis was performed by exon PCR covering all coding sequences and the corresponding exon-intron boundaries of the AHI1 gene in families F799, F700, F427 and F216. Exon PCR and direct sequencing in F799 revealed a homozygous single T nucleotide insertion (2369insT) within exon 16 in both affected siblings (II-2 and II-4) resulting in a frame shift and a subsequent stop codon at amino acid 791 (Fig. 2) . Segregation of the mutation was demonstrated with the mother and unaffected siblings II-1 and II-3 showing a heterozygous T nucleotide insertion.
AHI1 mutations were not detected in families F700, F427 and F216. Direct sequencing confirmed a lack of homozygosity in these families, revealing heterozygous intronic single-nucleotide polymorphisms (SNPs) within sequencing PCR amplicons (data not shown). Additional screening for AHI1 mutations in 20 additional individuals with JBTS revealed two compound heterozygous mutations within exon 6 of AHI1 in family F400 (Fig. 2) . The first mutation is a 324 heterozygous nucleotide deletion (365-688del) leading to an inframe deletion of 108 amino acids. The latter is a single A nucleotide insertion at position 444 leading to a frame shift and stop codon at amino acid 149. All mutations were absent from 96 healthy control individuals. Clinical features in JBTS patients with AHI1 mutations Family F799 originated from Pakistan. The affected individuals II-2 and II-4 were children of a consanguineous marriage whose parents were third degree cousins. The clinical features of both affected males in F799 included cerebellar ataxia, psychomotor developmental delay, nystagmus and oculomotor apraxia. The youngest sibling (II-4) had a salt and water-losing nephropathy leading to end-stage renal failure by the age of 16 years. Corticomedullary cysts were revealed on renal ultrasound, and a renal biopsy demonstrated changes consistent with nephronophthisis. The second affected sibling (II-2) had no renal symptoms, in particular no polyuria, and had not developed renal insufficiency by 20 years of age. However, this does not exclude a milder form of nephronophthisis in this patient. Siblings II-1 and II-3 remain healthy. Patient II-1 of family F400, of unknown ethnic origin, had JBTS associated with coloboma with no clinical evidence of nephronophthisis and no documented renal impairment. Additional clinical data, including renal ultrasound, were unavailable.
Discussion
We have detected, by direct mutational analysis in three patients, three novel mutations in AHI1, including one patient with NPHP-associated JBTS, one patient with JBTS without renal involvement and one patient with JBTS associated with coloboma. AHI1 is highly expressed in human brain and kidney [12] . Within the brain, there is AHI1 mRNA expression in both the cerebellum and cerebral cortex [12] consistent with the marked cerebellar ataxia seen JBTS patients. The AHI1 protein, also known as Jouberin, possesses several distinct protein domains, which include one coiled-coil, six WD40 domains and one SH3 domain. Based on these domains, a role for Jouberin as an adapter protein for protein-protein interactions has been postulated [11] .
Mutations in AHI1 have previously been described only in JBTS patients without a renal phenotype. Some of these patients had evidence of additional central nervous system abnormalities that included polymicrogyria [11] . These published mutations include two nonsense mutations, R351X and R435X, and a missense mutation V443D described by Ferland et al. [12] . The same missense mutation was also independently reported by Dixon-Salazar et al., in addition to two further frame shift mutations leading to truncations at codons 270 and 408, respectively [11] . Thus, four truncating mutations were previously reported, leading to a loss of WD40 domains and SH3 domain regions at the C-terminus of the protein.
All of these mutations were reported in JBTS patients without NPHP. Our report adds further genetic and clinical heterogeneity to patients with JBTS and AHI1 mutations, as the three novel mutations detected also lead to loss of both the SH3 domain and part or all of the WD40 domains in each case (Fig. 2B-E) . It is of note that, like Jouberin, nephrocystin-1 has both an SH3 domain and a coiled-coil domain; therefore, it is likely that these proteins may interact within a functional complex both in the kidney and the brain. Homozygous mutations in NPHP1 may sometimes lead to a JBTS phenotype, although this is rare. This implies that genotype and clinical phenotype correlations are difficult to make and that additional proteins within the nephrocystin-1/Jouberin complex may determine the phenotype via genetic modifiers. SH3 domains typically bind to PXXP amino acid motifs [18] , and indeed the AHI1 protein contains four PXXP motifs. Therefore, since similar truncating mutations were found in JBTS patients with and without NPHP, the position of the truncation does not seem to explain the presence or absence of renal involvement. One potential explanation could be the action of additional "modifier" genes, analogous to the related disorder Bardet-Biedl syndrome, the clinical spectrum of which includes renal failure [19] . In Bardet-Biedl syndrome oligogenic mutations may potentiate a phenotype that is caused by two disease-causing recessive mutations in an independent gene [19] .
In conclusion, AHI1 mutations are a cause of JBTS, and we demonstrate that novel truncating mutations are present in an affected individual with NPHP-associated JBTS. The role of AHI1 in renal cyst development and its interaction with other nephrocystins will require further investigation.
